However, several meta-analyses find that psychological debriefing is unhelpful and is potentially harmful. This is true for both single-session debriefing and multiple session interventions. As of 2017 the American Psychological Association assessed psychological debriefing as No Research Support/Treatment is Potentially Harmful. Risk-targeted interventions
Risk-targeted interventions are those that attempt to mitigate specific formative information or events. It can target modeling normal behaviors, instruction on a task, or giving information on the event. Management
Reviews of studies have found that combination therapy (psychological and pharmacotherapy) is no more effective than psychological therapy alone. Counselling
The approaches with the strongest evidence include behavioral and cognitive-behavioral therapies such as prolonged exposure therapy, cognitive processing therapy, and eye movement desensitization and reprocessing (EMDR). There is some evidence for brief eclectic psychotherapy (BEP), narrative exposure therapy (NET), and written exposure therapy.A 2019 Cochrane review evaluated couples and family therapies compared to no care and individual and group therapies for the treatment of PTSD. There were too few studies on couples therapies to determine if substantive benefits were derived but preliminary RCTs suggested that couples therapies may be beneficial for reducing PTSD symptoms.A meta-analytic comparison of EMDR and cognitive behavioral therapy (CBT) found both protocols indistinguishable in terms of effectiveness in treating PTSD; however, "the contribution of the eye movement component in EMDR to treatment outcome" is unclear. A meta-analysis in children and adolescents also found that EMDR was as efficacious as CBT.Children with PTSD are far more likely to pursue treatment at school (because of its proximity and ease) than at a free clinic.
They are so expensive that gene therapy for haemophilia might be less expensive, especially for people with severe hemophilia. See also
Damoctocog alfa pegol, a recombinant antihemophilic factor VIII
Efmoroctocog alfa, a recombinant antihemophilic factor VIII
Moroctocog alfa, a recombinant antihemophilic factor VIII
Susoctocog alfa, a recombinant antihemophilic factor VIII
Turoctocog alfa, a recombinant antihemophilic factor VIII

References
External links
"Blood-coagulation factor VIII, procoagulant". Drug Information Portal. U.S. National Library of Medicine. "Beroctocog alfa". Drug Information Portal. U.S. National Library of Medicine. "Antihemophilic Factor (Recombinant) Monograph for Professionals". Drugs.com. "Antihemophilic Factor (Recombinant), Porcine Sequence Monograph for Professionals". Drugs.com. "Antihemophilic Factor (recombinant), Fc Fusion Protein Monograph for Professionals". Drugs.com. "Antihemophilic Factor (recombinant), Glycopegylated-exei Monograph for Professionals". Drugs.com.